As the pipeline for oligonucleotide-based therapeutics continues to grow, with >300 currently in clinical trials, along with an increased demand for GMP/GLP-validated oligonucleotide reagents (including primers, probes, gRNA) for clinical DNA testing/sequencing, the need for robust, compliance-ready LC-MS analysis of oligonucleotides has never been greater.
Waters has designed the BioAccord LC-MS System to deliver robust, reproducible separations and accurate mass performance in a compact, easy-to-use format; one that facilitates deployment across regulated development, manufacturing and QC labs and supports a range of routine biopharmaceutical analyses, including oligonucleotide analysis. In this webinar, hear from Dr. Catalin Doneanu about recent work demonstrating the utility of the BioAccord LC-MS system and find out how this system has helped users analyze and monitor a diverse range of modified oligonucleotides and known impurities using the compliance-ready intact mass analysis workflow.
Who should attend?
This webinar will provide insights for:
Certificate of attendance
All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.
This webinar will run as two sessions, the first session will run on Wednesday, December 2, at:
The second session will run on Thursday, December 3, at:
SelectScience runs more than 10 webinars a month across various scientific topics, discover more of our webinars here>>